Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Mark Stephen McCollum Advocates for Stronger Execution and System Adoption in Automotive Retail
Via 24-7 Press Release
Topics Product Recall
Exposures Legal Product Safety
News headline image
The Sound of Serenity Quantum Healing Arts Introduces Ketamine-Assisted Meditation Events Through New Studio Partnership
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Emergent (EBS) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
Topics Bonds
Tickers EBS
Exposures Debt Markets Product Safety
News headline image
The Higgins Firm Investigating Dupixent Claims After FDA Flags Skin Cancer Risk
Via PRUnderground
Topics Lawsuit
Exposures Financial Legal Product Safety
News headline image
Agios (AGIO) Q3 2024 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers AGIO
Exposures Financial Product Safety
News headline image
Positive FDA Response on Preservative-Free Ketamine After President Trump Orders Accelerated Approval for Psychedelic Medication Developers Including NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Topics Government
Tickers NRXP
Exposures Political Product Safety
News headline image
Incyte (INCY) Q4 2024 Earnings Transcript ↗
Via The Motley Fool
Tickers INCY
Exposures Product Safety
News headline image
GE HealthCare (GEHC) Q4 2024 Earnings Transcript ↗
Via The Motley Fool
Tickers GEHC
Exposures Product Safety
News headline image
Axogen (AXGN) Q2 2025 Earnings Transcript ↗
Via The Motley Fool
Tickers AXGN
Exposures Product Safety
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives Positive FDA Review Letter Supporting Ketamine ANDA Progress
Via Investor Brand Network
Tickers BMWYY NRXP
Exposures Product Safety
News headline image
VPR Brands Retains McAndrews, Held & Malloy as Lead Patent Counsel for US Patent No. 8,205,622 B2
Via NewMediaWire
Topics Intellectual Property
Tickers VPRB
Exposures Intellectual Property Product Safety
VPR Brands Retains McAndrews, Held & Malloy as Lead Patent Counsel for US Patent No. 8,205,622 B2
Via TheNewswire.com
Topics Intellectual Property
Tickers VPRB
Exposures Intellectual Property Product Safety
News headline image
Why Intuitive Surgical Stock Soared Today ↗
Via The Motley Fool
Tickers ISRG
Exposures Product Safety
News headline image
How the Ford Recall of 1.4 Million F-150s Could Impact Investors ↗
Via The Motley Fool
Topics Product Recall
Tickers F
Exposures Legal Product Safety
News headline image
Dr. Emily J. Kirby Offers Motiva Preservé for Less Invasive Breast Augmentation
Via Press Advantage
Exposures Product Safety
News headline image
EXCLUSIVE: Adial Pharmaceuticals Clears Manufacturing Milestone Ahead Of Pivotal Study For Alcohol Use Disorder Drug ↗
Via Benzinga
Exposures Product Safety
News headline image
Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
Via Newsfile
Tickers ASX:COH COCH
Exposures Product Safety
News headline image
Sanofi Eyes First On-Body Injector Cancer Therapy As FDA Delays Decision ↗
Via Benzinga
Exposures Product Safety
News headline image
Frank Elsner Launches Personal Safety Culture Pledge for Workplaces
Via 24-7 Press Release
Topics Death Product Recall
Exposures Death Legal Product Safety
News headline image
New Castle Traumatic Brain Injury Attorney Lawrence M. Kelly Explains Memory Loss After Car Accidents in Pennsylvania
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
News headline image
Beta Bionics BBNX Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Tickers BBNX
Exposures Product Safety
News headline image
Stock Market Today, April 21: Hims & Hers Health Drops as Amazon Unveils Competing Weight Loss Program ↗
Via The Motley Fool
Topics Stocks
Tickers AMZN HIMS NVO
Exposures Product Safety US Equities
News headline image
Kopp Family Office Trims $3.5 Million Worth of Viridian Therapeutics Stake -- What Investors Should Know ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers VRDN
Exposures Legal Product Safety Regulatory
News headline image
Presidential Executive Order to Accelerate Approval of Psychedelic Medications; Those Being Developed by NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Topics Government
Tickers NRXP
Exposures Political Product Safety
News headline image
What Should Users Know When Bulk Purchasing Plastic Bottle
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
News headline image
Agios (AGIO) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers AGIO
Exposures Financial Product Safety
News headline image
Urban Edge (UE) Q2 2025 Earnings Transcript ↗
Via The Motley Fool
Tickers UE
Exposures Product Safety
News headline image
Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge
Via PRLog
Exposures Product Safety
News headline image
Agios (AGIO) Q3 2025 Earnings Transcript ↗
Via The Motley Fool
Tickers AGIO
Exposures Product Safety
News headline image
BXMT Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers BXMT
Exposures Financial Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.